We are live on ! Find out more
DHFB

Dixon Hubard Feinour & Brown Portfolio holdings

AUM $842M
1-Year Est. Return 2.74%
This Fund
S&P 500
This Quarter Est. Return
+24%
1 Year Est. Return
-2.74%
3 Year Est. Return
+59.78%
5 Year Est. Return
+118.87%
10 Year Est. Return
AUM
$385M
AUM Growth
+$89.8M
Cap. Flow
+$11.6M
Cap. Flow %
3.02%
Top 10 Hldgs %
35.04%
Holding
192
New
25
Increased
41
Reduced
78
Closed
6

Top Buys

Rank Stock Value
1
VEEV icon
Veeva Systems
VEEV
+$6.61M
2
NFLX icon
Netflix
NFLX
+$6.39M
3
ABBV icon
AbbVie
ABBV
+$6.08M
4
ABT icon
Abbott
ABT
+$5.42M
5
AKAM icon
Akamai
AKAM
+$5.29M

Top Sells

Rank Stock Value
1
LHX icon
L3Harris
LHX
+$6.27M
2
VWO icon
Vanguard FTSE Emerging Markets ETF
VWO
+$5.9M
3
JPM icon
JPMorgan Chase
JPM
+$5.57M
4
CMCSA icon
Comcast
CMCSA
+$4.85M
5
CPRT icon
Copart
CPRT
+$4.74M

Sector Composition

Rank Sector Weight
1 Healthcare 25.25%
2 Technology 22.34%
3 Consumer Discretionary 11.07%
4 Communication Services 9.13%
5 Consumer Staples 7.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NSC icon
26
Norfolk Southern
NSC
$75.1B
$4.65M 1.21%
25,119
-500
-2% -$84.7K
AMT icon
27
American Tower
AMT
$80.4B
$4.62M 1.2%
+17,314
New +$4.28M
LLY icon
28
Eli Lilly
LLY
$1.06T
$4.15M 1.08%
25,537
-680
-3% -$104K
INTC icon
29
Intel
INTC
$513B
$3.9M 1.01%
79,134
+2,481
+3% +$148K
PEP icon
30
PepsiCo
PEP
$190B
$3.7M 0.96%
26,923
+180
+0.7% +$23.7K
CSCO icon
31
Cisco
CSCO
$479B
$3.54M 0.92%
76,496
-2,462
-3% -$108K
BMY icon
32
Bristol-Myers Squibb
BMY
$132B
$3.35M 0.87%
56,289
+795
+1% +$47.6K
SO icon
33
Southern Company
SO
$107B
$3.19M 0.83%
57,609
-2,757
-5% -$153K
XOM icon
34
ExxonMobil
XOM
$634B
$3.05M 0.79%
70,097
+881
+1% +$39.5K
ED icon
35
Consolidated Edison
ED
$39.9B
$3.03M 0.79%
39,645
-304
-0.8% -$23.3K
D icon
36
Dominion Energy
D
$59.3B
$2.66M 0.69%
32,424
+425
+1% +$34.1K
TFC icon
37
Truist Financial
TFC
$64B
$2.53M 0.66%
68,653
+471
+0.7% +$17K
BRK.B icon
38
Berkshire Hathaway Class B
BRK.B
$1.13T
$2.5M 0.65%
12,864
+200
+2% +$36.5K
MRK icon
39
Merck
MRK
$318B
$2.25M 0.59%
29,662
-503
-2% -$37.9K
DXCM icon
40
DexCom
DXCM
$32B
$2.25M 0.58%
21,500
+260
+1% +$23.3K
VUG icon
41
Vanguard Morningstar Growth ETF
VUG
$231B
$2.03M 0.53%
57,756
+23,274
+67% +$716K
T icon
42
AT&T
T
$163B
$2.03M 0.53%
90,393
-3,815
-4% -$86.9K
RGCO icon
43
RGC Resources
RGCO
$228M
$1.73M 0.45%
75,996
-2,100
-3% -$53.4K
DUK icon
44
Duke Energy
DUK
$97.3B
$1.72M 0.45%
20,323
-263
-1% -$22.2K
JPC icon
45
Nuveen Preferred & Income Opportunities Fund
JPC
$2.9B
$1.63M 0.42%
190,200
-4,500
-2% -$35.9K
VNQ icon
46
Vanguard Real Estate ETF
VNQ
$39B
$1.59M 0.41%
19,703
+3,797
+24% +$288K
VWO icon
47
Vanguard FTSE Emerging Markets ETF
VWO
$124B
$1.57M 0.41%
36,515
-159,462
-81% -$5.9M
EFX icon
48
Equifax
EFX
$21.4B
$1.56M 0.41%
9,623
-45
-0.5% -$6.67K
TRV icon
49
Travelers Companies
TRV
$80.2B
$1.54M 0.4%
13,375
-76
-0.6% -$8.01K
KO icon
50
Coca-Cola
KO
$375B
$1.51M 0.39%
31,319
+818
+3% +$37.7K

Similar funds

Dixon Hubard Feinour & Brown's Q2 2020 Portfolio in Review

As of Q2 2020, Dixon Hubard Feinour & Brown held 192 positions worth $385M, up 30% from $296M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Dixon Hubard Feinour & Brown deployed $11.6M of net new capital in Q2 2020, opening 25 new positions and adding to 41 existing holdings. Its largest new stake was Veeva Systems: 33,309 shares worth $8.36M.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, up from 20% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Vanguard FTSE Emerging Markets ETF, an estimated $5.9M trimmed.

  • Dixon Hubard Feinour & Brown's largest Q2 2020 buy was Veeva Systems: 33,309 shares worth $8.36M.
  • Dixon Hubard Feinour & Brown added most to AbbVie in Q2 2020, an estimated $6.08M increase.
  • Dixon Hubard Feinour & Brown's biggest Q2 2020 reduction was Vanguard FTSE Emerging Markets ETF, cutting an estimated $5.9M.
  • Dixon Hubard Feinour & Brown fully exited L3Harris in Q2 2020, selling an estimated $6.27M.
  • Dixon Hubard Feinour & Brown's ten largest holdings make up 35% of its $385M portfolio in Q2 2020.
  • Dixon Hubard Feinour & Brown opened 25 new positions and closed 6 in Q2 2020.
  • Dixon Hubard Feinour & Brown's portfolio value rose 30% quarter-over-quarter to $385M.

Based on Dixon Hubard Feinour & Brown's 13F filing for Q2 2020, filed 31 Jul 2020.